← All patents

US20230227526A1

Engineered t cell receptors and methods of use

University of Texas System

Abstract

This disclosure provides for engineered T cell Receptors (TCRs), cells comprising the TCRs, and methods of making and using the TCRs. The current disclosure relates to TCRs that specifically recognize epitope(s) from tumor antigen COL6A3. Accordingly, aspects of the disclosure relate to an …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Cassian Yee
Priority date
June 09, 2020
Filing date
June 08, 2021
Publication date
July 20, 2023
Language
en
Metadata fetched
August 29, 2026 00:31